Pediatric dermatotherapy;Pädiatrische dermatotherapie

Hautarzt

Volumn 54, Issue 1, 2003, Pages 10-13

  Vogel, M ^a   Brockow, K ^a   Abeck, D ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Atopic dermatitis; Borreliosis; Mastocytosis; Psoriasis; Scabies; Skin physiology

Indexed keywords

ANTIHISTAMINIC AGENT; BENZYL BENZOATE; CALCINEURIN INHIBITOR; CALCIPOTRIOL; CALCITRIOL; CEFUROXIME AXETIL; CETIRIZINE; CLEMASTINE; CLEMASTINE FUMARATE; CROTAMITON; DERMATOLOGICAL AGENT; DESLORATADINE; DIMETINDENE; DOXYCYCLINE; ERAXIL; ERYTHROMYCIN; GLUCOCORTICOID; HEXACHLOROCYCLOHEXANE; HYDROCORTISONE BUTYRATE; HYDROXYZINE; IVERMECTIN; LEVOCETIRIZINE; LINDANE; METHYLPREDNISOLONE ACEPONATE; MOMETASONE FUROATE; PERMETHRIN; PIMECROLIMUS; PREDNICARBATE; TACALCITOL; TACROLIMUS; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN D DERIVATIVE;

ARTICLE; ATOPIC DERMATITIS; BORRELIA INFECTION; CHILD; DERMATOLOGY; HUMAN; MASTOCYTOSIS; PEDIATRICS; PROGNOSIS; PSORIASIS; SCABIES; SIDE EFFECT; SKIN DISEASE; ADULT; CLINICAL TRIAL; COMPARATIVE STUDY; DOSE RESPONSE; INFANT; NEWBORN; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADULT; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; DERMATOLOGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFANT; INFANT, NEWBORN; SKIN DISEASES;

EID: 0038266809     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-002-0473-2     Document Type: Article

References (25)

1. Abeck D, Cremer H (1999) Häufige Hautkrankheiten im Kindesalter: Klinik Diagnose Therapie, 2. Aufl. Darmstadt: Steinkopff, S 135-137
2. Björnberg A, Molacken A (1972) Necrotic skin reactions caused by 1% gentianaviolet and brilliantgreen. Acta Derm Venerol (Stockh) 52:55
3. Braun-Falco O, Plewig G, Wolff HH (1996) Äußerliche Dermatotherapie. In: Braun-Falco O, Plewig G, Wolff HH (Hrsg) Dermatologie und Venerologie, 4. Aufl. Springer, Berlin Heidelberg New York Tokyo, S 1527
4. Brooks PA, Grace RF (2002) Ivermectin is better than benzyl benzoate for childhood scabies in developing countries. J Paediatr Child Health 38:401-404
5. Evans N, Rutter N (1986) Development of the epidermis in the newborn. Biol Neonate 49:74-80
6. Folster-Holst R, Rufli T, Christophers E (2000) Die Skabiestherapie unter besonderer Berücksichtigung des frühen Kindesalters, der Schwangerschaft und Stillzeit. Hautarzt 51:7-13
7. Forth W, Henschler D, Rummel W, Starke K (1992) Allgemeine und spezielle Pharmakologie und Toxikologie, 6. Aufl.Bl Wissenschaftsverlag Mannheim Leipzig Wien Zürich
8. Harpin V, Rutter N (1983) Barrierproperties of the newborn infant0s skin. J Pediatr 102:419-425
9. Hartmann K, Metcalfe DD (2000) Pediatric mastocytosis. Hematol Oncol Clin North Am 14:625-640
10. Hartmann K, Henz BM (2001) Mastocytosis: recent advaces in defining the disease. Br J Dermatol 144:682-695
11. Has C, Misery L, David L, Cambazard F (2002) Recurring staphylococcal scaled skin syndrome-like bullous mastocytosis: the utility of cytodiagnosis and the rapid regression with steroids. Pediatr Dermatol 19:220-223
12. Haustein UF, Bedri M (1997) Bullöse Mastozytose bei einem Kind. Hautarzt 48:127-129
13. Korting HC, Kerscher MJ, Schäfer-Korting M (1992) Topical glucocorticoids with improved benefit/risk ratio: do they exist? J Am Acad Dermatol 27:87-92
14. Korting HC, Unholzer A, Schäfer-Korting M et.al. (2002) Different skin thinning potential of equipotent medium-strength glucocorticoids. Skin Pharmacol Appl Skin Physiol 15:85-91
15. Loewen PS, Marra CA, Marra F (1999) Systematic review of the treatment of early Lyme disease. Drugs 57:157-173
16. Lübbe J, Pournaras CC, Saurat JH (2000) Eczema herpeticum during treatment of atopic dermatitis with 0,1% tacrolimus ointment. Dermatology 201:249-251
17. McCloskey SE, Gershanik JJ, Lertora JJ et al. (1982) The gasping syndrome and benzyl alcohol poisoning. N Engl J Med 307:1384-1388
18. Nghiem P, Pearson G, Langley RG (2002) Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol 46:228-241
19. Niedner R (1993) Kortikosteroide bei Hautkrankheiten externe und systemische Anwendung. Bayer Int 13:3-11
20. Roos TC, Alam M, Roos S et al. (2001) Pharmacotherapy of ectoparasitic infections. Drugs 61:1067-1088
21. Swanbeck G (1992) Urea in the treatment of dry skin. Acta Derm Venerol (Stockh) 177:7-8
22. Vaidhyanathan U (2001) Review of ivermectin in scabies. J Cutan Med Surg 5:496-504
23. Wahn U, Bos JD, Goodfield M et.al. (2002) Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics 110:e2
24. Werfel S, Boeck K, Abeck D, Ring J (1998) Besonderheiten der topischen Behandlung im Kindesalter. Hautarzt 49:170-175
25. West D, Worobec S, Solomon L (1981) Pharmacology and toxicology of infant skin. J Invest Dermatol 76:147-150